Related by context. Frequent words. (Click for all words.) 63 target lesion revascularization 63 myocardial infarction stroke 61 Secondary endpoints 61 discontinuations due 60 composite endpoint 60 Secondary endpoints included 60 coronary revascularization 59 Secondary endpoints include 59 thromboembolic events 59 Pharmacokinetic 59 acute coronary 59 myocardial infarction MI 59 Acute Coronary Syndrome 59 tumor lysis syndrome 58 secondary endpoint 58 treatment emergent adverse 58 LVEF 58 CYPHER ® Stent 58 spinal cord compression 58 annualized relapse 57 thromboembolism 57 Main Outcome Measures 57 rehospitalization 57 secondary efficacy endpoints 57 Myocardial Infarction 57 neoadjuvant 57 cardiovascular hospitalization 57 Cardiovascular Risk 56 ADAS cog 56 fondaparinux 56 virologic failure 56 TAXUS 56 Stenting 56 sustained virologic response 56 fasting plasma glucose 56 stent thrombosis 55 TIMI 55 prespecified 55 thrombotic events 55 virologic response 55 Postoperative 55 stent implantation 55 infarct size 55 QTc 55 lipid lowering drugs 55 acute myocardial infarction AMI 55 cytogenetic response 55 evaluable 55 reoperation 55 TAXUS stent 55 mg BID 55 myocardial infarction 55 echocardiographic 55 target vessel revascularization 54 SPIRIT III 54 myocardial infarctions 54 laboratory abnormalities 54 acute myocardial infarction 54 stent restenosis 54 Monotherapy 54 vertebral fracture 54 Endpoints 54 HbA1c levels 54 neoadjuvant chemotherapy 54 nonsignificant 54 febrile neutropenia 54 decitabine 54 carotid endarterectomy 54 CD4 + cell 54 Recurrence 54 C Reactive Protein 53 CYPHER R Stent 53 sinus rhythm 53 hypomagnesemia 53 microalbuminuria 53 cardiac dysfunction 53 left ventricular dysfunction 53 ST elevation myocardial 53 MACE 53 ADHF 53 eGFR 53 morbidity mortality 53 abciximab 53 candesartan 53 pharmacodynamic 53 P = .# 53 noninferiority 53 bosentan 53 primary endpoint 53 stroke myocardial infarction 53 rosuvastatin 52 glomerular filtration rate 52 revascularization 52 IPSS 52 tumor recurrence 52 NYHA class 52 bivalirudin 52 histologic 52 subgroup analyzes 52 plus methotrexate 52 venous thromboembolism